CH Biotech R&D Co., Ltd. (6534.TW)

TWD 80.6

(-0.49%)

Operating Expenses Summary of CH Biotech R&D Co., Ltd.

  • CH Biotech R&D Co., Ltd.'s latest annual operating expenses in 2023 was 694.23 Million TWD , up 11.34% from previous year.
  • CH Biotech R&D Co., Ltd.'s latest quarterly operating expenses in 2024 Q2 was 190.37 Million TWD , down -12.44% from previous quarter.
  • CH Biotech R&D Co., Ltd. reported a annual operating expenses of 623.53 Million TWD in annual operating expenses 2022, up 27.6% from previous year.
  • CH Biotech R&D Co., Ltd. reported a annual operating expenses of 488.67 Million TWD in annual operating expenses 2021, up 9.83% from previous year.
  • CH Biotech R&D Co., Ltd. reported a quarterly operating expenses of 217.43 Million TWD for 2024 Q1, up 31.71% from previous quarter.
  • CH Biotech R&D Co., Ltd. reported a quarterly operating expenses of 165.09 Million TWD for 2023 Q4, down -2.2% from previous quarter.

Annual Operating Expenses Chart of CH Biotech R&D Co., Ltd. (2023 - 2019)

Historical Annual Operating Expenses of CH Biotech R&D Co., Ltd. (2023 - 2019)

Year Operating Expenses Operating Expenses Growth
2023 694.23 Million TWD 11.34%
2022 623.53 Million TWD 27.6%
2021 488.67 Million TWD 9.83%
2020 444.93 Million TWD 1.29%
2019 439.28 Million TWD 0.0%

Peer Operating Expenses Comparison of CH Biotech R&D Co., Ltd.

Name Operating Expenses Operating Expenses Difference
Sinon Corporation 5.19 Billion TWD 86.648%
Taiwan Fertilizer Co., Ltd. 1.3 Billion TWD 46.99%
All Cosmos Bio-Tech Holding Corporation 375.98 Million TWD -84.643%